STOCK TITAN

iRhythm (IRTC) Form 144: Marc Rosenbaum to Sell 226 Shares on NASDAQ

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 filed for iRhythm Technologies (IRTC) shows an insider intends to sell a small block of common stock through Morgan Stanley Smith Barney on NASDAQ. The notice specifies 226 shares with an aggregate market value of $35,918.18, acquired under the company Employee Stock Purchase Plan on 11/30/2023 and paid for in cash. The filer previously sold 696 shares on 06/02/2025 for $97,586.16. With 32,127,763 shares outstanding reported on the form, the planned sale represents approximately 0.0007% of the outstanding shares, indicating the transaction is immaterial to total equity. The filer certifies there is no undisclosed material adverse information and includes standard Rule 10b5-1 language if applicable.

Positive

  • None.

Negative

  • None.

Insights

TL;DR Insider plans to sell a very small stake—transaction size is immaterial relative to shares outstanding.

The Form 144 discloses a proposed sale of 226 common shares valued at $35,918.18 through Morgan Stanley Smith Barney on NASDAQ. The shares were acquired via the Employee Stock Purchase Plan on 11/30/2023. A prior sale of 696 shares on 06/02/2025 generated $97,586.16. Relative to the 32,127,763 shares outstanding shown on the form, the current notice represents about 0.0007% of outstanding shares, which is unlikely to alter market perception or company valuation. Disclosure appears routine and consistent with insider liquidity under an ESPP.

TL;DR Filing reflects routine insider liquidity; no governance red flags evident from disclosed facts.

The notice includes required attestations that no undisclosed material adverse information exists and references possible Rule 10b5-1 instructions. The transaction size and prior recent sale suggest opportunistic, small-scale disposition of shares acquired through an ESPP rather than a vote of no confidence by management. All material items in the form are disclosed: acquisition method, payment type, broker, amounts, and past three-month sales, meeting regulatory transparency expectations.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the IRTC Form 144 disclose about the planned sale?

The form discloses a proposed sale of 226 common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $35,918.18.

Who is the seller listed on the IRTC Form 144?

The seller identified in the filing is Marc Rosenbaum, with prior reported sales included on the form.

When were the shares being sold originally acquired?

The 226 shares were acquired under the company's Employee Stock Purchase Plan on 11/30/2023 and paid for in cash.

Has the filer sold other IRTC shares recently?

Yes. The form reports a sale of 696 shares on 06/02/2025 that produced $97,586.16 in gross proceeds.

How material is the planned sale relative to IRTC's outstanding shares?

With 32,127,763 shares outstanding shown, the 226-share sale represents about 0.0007% of outstanding shares, which is immaterial to overall equity.
iRhythm Holdings, Inc

NASDAQ:IRTC

IRTC Rankings

IRTC Latest News

IRTC Latest SEC Filings

IRTC Stock Data

4.65B
29.29M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
San Francisco